Correlation Between Kilitch Drugs and Beta Drugs

Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kilitch Drugs Limited and Beta Drugs, you can compare the effects of market volatilities on Kilitch Drugs and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Beta Drugs.

Diversification Opportunities for Kilitch Drugs and Beta Drugs

0.33

Correlation Coefficient

Kilitch Drugs  Beta Drugs

Weak diversification

The 3 months correlation between Kilitch and Beta is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Beta Drugs go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Beta Drugs

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to generate 0.61 times more return on investment than Beta Drugs. However, Kilitch Drugs Limited is 1.65 times less risky than Beta Drugs. It trades about 0.0 of its potential returns per unit of risk. Beta Drugs is currently generating about -0.11 per unit of risk. If you would invest  31,495  in Kilitch Drugs Limited on November 30, 2024 and sell it today you would lose (595.00) from holding Kilitch Drugs Limited or give up 1.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Kilitch Drugs Limited  vs.  Beta Drugs

Kilitch Drugs Limited

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Beta Drugs

Risk-Adjusted Performance

Very Weak

Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Kilitch Drugs and Beta Drugs

The main advantage of trading using opposite Kilitch Drugs and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.

The idea behind Kilitch Drugs Limited and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.